Seres Therapeutics

Seres is a clinical-stage biotechnology company developing novel live biotherapeutics, with a focus on inflammatory and immune diseases. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2016
Stage of Initial Investment
Series C
Initial Investment Year
2014